Silverback Therapeutics

Silverback Therapeutics

Silverback Therapeutics

Silverback Therapeutics is charting a new path for treating a range of severe diseases.
Founded
2016
Raised
$126M
Follow us
Alexa global traffic share
Latest funding Show all
$78,500,000
Venture capital (Series B) - 2020
U.S. Venture Partners (USVP) Alexandria Venture Investments Nextech Invest Ltd. +5
$37,500,000
Venture capital (Series A) - 2018
Team Size
10+
Employees
Xconomy

Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec

$78,500,000 Venture capital (Series B)
GeekWire

Seattle biotech startup Silverback Therapeutics raises $78.5M

$37,500,000 Venture capital (Series A)
FinSMEs , PE HUB

Silverback Therapeutics Extends Series A to $47.5M

Funding Health
GeekWire

Silverback Therapeutics raises $37.5M, unveils tech that targets therapies to disease locations

$10,000,000 Venture capital
GeekWire , sec

Neurosurgery professor raises cash for stealthy biotech startup Silverback Therapeutics

Robotics Funding Health